Squamous cell neoplasms and carcinomas of the skin

PheWeb

C3_SQUOMOUS_CELL_CARCINOMA_SKIN

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 C44.02, C44.12, C44.22, C44.32, C44.42, C44.52, C44.62, C44.72, C44.82, C44.92

Hospital discharge: ICD-9 173[0-9]B

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 C44.02, C44.12, C44.22, C44.32, C44.42, C44.52, C44.62, C44.72, C44.82, C44.92

Cause of death: ICD-9 173[0-9]B

Cause of death: ICD-8 $!$

Cancer registry: Topography ICD-O-3 C44

Cancer registry: Morphology ICD-O-3 807[0-7]|808[2-4]

Cancer registry: Behaviour codes [23]

16827

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

2334

Check minimum number of events None

2334

Include endpoints None

2334

C3_SQUOMOUS_CELL_CARCINOMA_SKIN

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF7

Similar endpoints

↥

List of similar endpoints to Squamous cell neoplasms and carcinomas of the skin based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	2249	812	1437
Unadjusted prevalence (%)	0.73	0.47	1.06
Mean age at first event (years)	72.78	71.77	73.35

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.21 [1.59, 3.07]	2.7e-6	475
15 years	0.01	0.86 [0.61, 1.21]	3.9e-1	173
5 years	0.00	2.30 [1.76, 3.01]	1.1e-9	198
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_SQUOMOUS_CELL_CARCINOMA_SKIN – Squamous cell neoplasms and carcinomas of the skin
GWS hits:

Survival analyses between endpoints

↥

Plot

before Squamous cell neoplasms and carcinomas of the skin
after Squamous cell neoplasms and carcinomas of the skin

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Squamous cell neoplasms and carcinomas of the skin

↥